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Background: In 2011 there were 5.5 million HIV infected people in South Africa and 71% of those requiring
antiretroviral therapy (ART) received it. The effective integration of traditional medical practitioners and biomedical
providers in HIV prevention and care has been demonstrated. However concerns remain that the use of traditional
treatments for HIV-related disease may lead to pharmacokinetic interactions between herbal remedies and ART
drugs and delay ART initiation. Here we analyse the changing prevalence and determinants of traditional healthcare
use amongst those dying of HIV-related disease, pulmonary tuberculosis and other causes in a rural South African
community between 2003 and 2011. ART was made available in this area in the latter part of this period.
Methods: Data was collected during household visits and verbal autopsy interviews. InterVA-4 was used to assign
causes of death. Spatial analyses of the distribution of traditional healthcare use were performed. Logistic regression
models were developed to test associations of determinants with traditional healthcare use.
Results: There were 5929 deaths in the study population of which 47.7% were caused by HIV-related disease or
pulmonary tuberculosis (HIV/AIDS and TB). Traditional healthcare use declined for all deaths, with higher levels
throughout for those dying of HIV/AIDS and TB than for those dying of other causes. In 2003-2005, sole use of
biomedical treatment was reported for 18.2% of HIV/AIDS and TB deaths and 27.2% of other deaths, by 2008–2011
the figures were 49.9% and 45.3% respectively. In bivariate analyses, higher traditional healthcare use was associated
with Mozambican origin, lower education levels, death in 2003–2005 compared to the later time periods, longer
illness duration and moderate increases in prior household mortality. In the multivariate model only country of
origin, time period and illness duration remained associated.
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Conclusions: There were large decreases in reported traditional healthcare use and increases in the sole use of
biomedical treatment amongst those dying of HIV/AIDS and TB. No associations between socio-economic position,
age or gender and the likelihood of traditional healthcare use were seen. Further qualitative and quantitative studies
are needed to assess whether these figures reflect trends in healthcare use amongst the entire population and the
reasons for the temporal changes identified.
Keywords: Traditional medical practitioner, Traditional medicine, Antiretroviral therapy, HIV, AIDS, Mortality,
Tuberculosis, Demographic surveillance system, South Africa, Sub-Saharan Africa, Risk factorBackground
Traditional Medical Practitioners (TMPs) are an important
component of the available healthcare resources in South
Africa. They often provide services with greater cultural
acceptability and geographical accessibility than their bio-
medical counterparts [1]. The World Health Organization
(WHO) defines traditional medicine as referring to ‘health
practices, approaches, knowledge and beliefs incorporating
plant, animal and mineral based medicines, spiritual
therapies, manual techniques and exercises, applied singu-
larly or in combination to treat, diagnose and prevent
illnesses or maintain well-being’ [2]. In South Africa
these practitioners include herbalists (izinyanga/inyanga or
amaxhwele), diviners (izangoma/sangoma or amagqirha),
traditional surgeons and traditional birth attendants [3]. In
the treatment of HIV-related conditions, the holistic em-
phasis of the care provided by TMPs addressing psycho-
social and physical aspects of disease has the potential to
complement biomedical treatments and has led to efforts
to integrate them with biomedical practitioners in the diag-
nosis and treatment of those with HIV [1,4,5]. They have
been reported to also have an important role to play in pal-
liative care for those with HIV/AIDS [6,7]. Evidence from
studies conducted prior to 1994 indicated that when trad-
itional healers are properly trained they can make a useful
contribution to HIV prevention, care and support [5]. More
recently, notable successes in linking traditional healers
with those in other health sectors have been reported from
projects in Tanzania, Uganda, Zambia, Malawi and other
sub-Saharan African countries , although there have been a
lack of systematic evaluations of these interventions [5].
As TMPs share the same socio-cultural beliefs as their
communities, they have the potential to be effective
communicators of health information [8]. It has been
estimated that 70 - 80% of South Africans consult TMPs
[9] although there is evidence for a decline in use in
recent years [3]. Amongst the possible explanations for
this reduction are that there has been an increased belief
in the efficacy of biomedical treatment [3] and that some
churches have discouraged their members from seeking
traditional medical care [10,11].
In 2011 the prevalence of HIV amongst males and
females in South Africa aged 15 – 49 was estimated tobe 17.6% with a total of 5.5 million people infected by
HIV [12]. In the early stages of the epidemic there was
scepticism on the part of the South African government
about the link between the HIV virus and the developing
AIDS pandemic and also doubts about the efficacy of
antiretroviral therapy (ART) for treating the condition
[13]. At the same time the use of herbal medicines to
treat those infected with HIV was promoted by the South
African Ministry of Health [14]. ART was made available
to patients in the South African public health system in
2003 but there were delays in the national roll-out par-
ticularly in rural areas [15]. Estimates by WHO/UNAIDS
and UNICEF indicate that ART coverage in South Africa
in 2011 was 71% [16]. The availability of ART in South
Africa has led to significant decreases in HIV-related mor-
tality [17,18].
There is evidence of pharmacokinetic interactions be-
tween certain herbal treatments and ART drugs [14,19,20].
Some studies have shown that patients using herbal treat-
ments in conjunction with ART are more likely to take
gaps in treatment or reduce their level of adherence
[21,22]. There are also concerns that those using herbal
remedies to treat HIV-related symptoms prior to starting
ART may delay the initiation of treatment [23]. An associ-
ation between the use of traditional medicine and delayed
initiation of TB treatment was identified in a rural hospital
in South Africa in 2006 [24].
Seeking treatment from TMPs can also place a signifi-
cant financial burden on the patient and their family at a
time when household resources are likely to be under con-
siderable strain [25]. Babb et al. reporting on individuals
attending a workplace ART clinic [26] and Case et al. who
interviewed family members of the deceased [27], both
noted the high cost of a course of treatment from a herb-
alist. In the latter study carried out in KwaZulu-Natal in
South Africa between 2003 and 2004 the average cost of
treatment by a traditional herbalist was found to be R433
(approximately 40 USD at the time) which was reported
to be more than 4 times the median monthly per-capita
income [27].
Between 2002 and 2003 a study of healthcare related
beliefs was carried out in the Agincourt sub-district of
Bushbuckridge in South Africa [28]. This concluded that
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selected from the available treatment providers based on
their perception of the relative efficacies of the treatments
offered. This study also found that late stage HIV-disease
related symptoms were often interpreted as evidence of
bewitchment and hence appropriate for treatment by trad-
itional healers [28,29]. This was in contrast to tuberculosis,
for which the community had evidence of the effectiveness
of the available short-course drug regimen [28]. Also prior
to the ART roll-out some traditional healers in the
Agincourt sub-district promoted treatments that were
claimed to cure HIV [29]. A study of verbal autopsy data
collected in the same area as the current study in 2006 [30]
showed that witchcraft remained a common explanation
for death at that time and that traditional remedies either
used alone or in conjunction with biomedical treatments
were commonly used to treat those perceived as bewitched.
With the availability of ART, patterns of medical plural-
ism became evident. A study of HIV clinic attendees car-
ried out in the Agincourt sub-district between 2006 and
2007 identified that 5 out of 32 participants used informal
sources of healthcare, which included traditional healers,
as their first interaction with the medical system [23]. This
study also found that the majority of the population
remained in the public system after ART initiation whilst
a minority switched between formal, informal and private
sources of care over time.
A 2005 study in Gabon [31] and a 2008−2011 study in
Kampala, Uganda [32] found that patients who had
reported having received treatment from traditional
healers or other informal sources had lower CD4 counts
at treatment initiation. However no such association was
found in another Ugandan study which recruited patients
between 2005 and 2009 [33].
A 2007−2009 study carried out in KwaZulu-Natal,
South Africa showed a significant decline in the parallel
use of traditional medicines and ART from 36% at the ini-
tiation of treatment to 8% at 6 months, 4.1% at 12 months
and 0.6% after 2 years treatment [21].
Previous South African studies have identified determi-
nants associated with the use of traditional healthcare
amongst HIV infected individuals. A 2003−2004 study in
Northern KwaZulu-Natal [27] reported an increase in the
use of traditional healers for females compared to males,
those with higher levels of education, lower numbers of
household assets, of a younger age and those who had
been ill for a longer period. In a study of 618 treatment
naïve patients attending an HIV clinic in KwaZulu-Natal
between 2007 and 2008 [34] it was found that being on a
disability grant and having fewer clinic visits increased the
likelihood of a reported use of herbal treatments. A small
pilot study in 2012 carried out in two South African sites,
one in rural KwaZulu-Natal, the other an urban area of
the Western Cape [35] found that having a rural dwelling,female gender, older age, a lack of formal education, not
being married, having employment and having been HIV
positive for less than 5 years were all predictors of trad-
itional medicine use amongst people living with AIDS.
The small sample size of this study however meant that
none of the associations were statistically significant. A
cross-sectional study of 334 patients at an HIV clinic in
Western Uganda in 2010 [36] found that longer periods of
time since ART initiation, greater numbers of ART side
effects, lower levels of knowledge about ART and poorer
self-perceived health status were all independently associ-
ated with concomitant herbal medicine and ART use, how-
ever no evidence for decreased ART adherence amongst
the patients taking traditional medicines was found. In
contrast to this a 2008 study in Uganda found that patients
who had been on ART for less than 4 years were more
likely to use traditional herbal medicines (THM) [37]. In
addition this study found higher levels of use of THM
amongst those experiencing side effects of ART, those less
than 39 years old and those with ART adherence levels less
than 95%.
A study [38] surveying traditional healthcare use in
Ghana identified an association between rising income
and an increased use of biomedical treatment whereas
decreasing income was associated with a greater use of
traditional medicine.
In the present study we analysed differences in the preva-
lence of the reported use of traditional and biomedical
healthcare between those dying of HIV-related disease and
pulmonary tuberculosis and those dying of other conditions
and how the usage changed over time. The study used data
collected between 2003 and 2011, the period during which
ART became available in the area. We assessed determi-
nants of traditional medicine use amongst those dying of
HIV/AIDS related diseases and pulmonary tuberculosis.
Methods
Study setting
The data was collected from village communities in the
Agincourt sub-district of Bushbuckridge Municipality in
Mpumalanga province in north-eastern South Africa.
The MRC/Wits Agincourt research unit has been running
a Health and Socio-Demographic Surveillance System
(HDSS) monitoring vital events in this area since 1992
[39]. The area is predominantly rural with nearby peri-
urban settlements and has high levels of unemployment
and poverty and low levels of educational attainment. Ap-
proximately one-third of the population are of Mozambican
descent, the majority of these having been displaced by the
Mozambican civil war (1977–1992) [40]. Voluntary coun-
selling and testing (VCT) for HIV has been available at
public health clinics in the study area since 1999 [41]. In
the public sector ART has been available from two public
hospitals serving the site since 2004 and from three local
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capacity to enrol limited numbers at these clinics but cap-
acity has subsequently improved [42,43].
Between August 2010 and May 2011 an HIV preva-
lence survey was conducted in the study site. It showed
an overall HIV prevalence of 19.4% (10.6% for males and
23.9% for females). An analysis by age group showed a
peak prevalence of over 45% in both males and females
aged between 35–39 years. The HIV prevalence in those
of South African origin was lower than for those from
Mozambique [44].
The study population consists of adults (aged over 18)
who died in the study site between 2003 and 2011 for
whom healthcare utilisation data was available.
Data collection
Individual and household level data were collected from
the most knowledgeable available household member by
trained fieldworkers during the annual census update
visit. In households where a death was reported a visit
was carried out by a specially trained fieldworker during
which a verbal autopsy (VA) interview was completed
with the person responsible for the care of the deceased
during their terminal illness or the closest available proxy.
This was done in order to determine the symptoms and
circumstances associated with the illness leading to death
[39,45]. A health care utilisation (HCU) module was in-
troduced to the Agincourt HDSS VA instrument in
2003 and included questions on the deceased’s use of trad-
itional treatments. The HCU module questionnaire used
with the Agincourt HDSS VA questionnaire is included as
Additional file 1 in the additional materials.
Data analysis
Cause of death (CoD) was assigned using the InterVA-4
model, which estimates the likelihood of a particular CoD
based on signs and symptoms reported by the VA respond-
ent [46,47]. InterVA-4 is fully aligned to the questions and
CoD assignments in the WHO-2012 VA instrument [48].
A previous study has shown a close correlation between
clinician’s assessments and InterVA-4 assignments for
HIV-disease related deaths [49]. The input variables for the
InterVA-4 model were derived from the Agincourt VA
questionnaire either by direct matching or identifying indi-
cator specific words or phrases in narrative fields.
Data from 2009 [50] indicated that approximately 70%
of those infected with pulmonary tuberculosis (TB) were
co-infected with HIV in South Africa. A very high level
of HIV co-infection amongst those dying of pulmonary
TB has also been reported in a survey of various sites
across sub-Saharan Africa [51]. Due to this high level of
co-morbidity deaths due to HIV-related disease and
pulmonary tuberculosis were joined in a single category,
HIV/AIDS and TB. All other deaths were assigned tothe category ‘Other Causes’ expect for those deemed to be
accidental or self-inflicted, which were defined as ‘External’.
When the respondent reported the use of a TMP or self
administration of herbal remedies the case was assigned
as use of traditional healthcare (TH). The time period was
broken down into 3 year categories: 2003–2005 (the
period before ART became available in the study area);
2006–2008 (the period during which limited numbers of
people were accessing ART in some local clinics) and
2009–2011 (when ART was made accessible in the public
healthcare system in the area).
A map was produced using the ArcGIS software [52],
showing the location of residence and whether TH use
was reported for each deceased person. Spatial coordi-
nates were randomly adjusted by between −0.5 km and
0.5 km in X and Y directions to protect anonymity. This
was carried out in order to allow a visual investigation of
whether there was evidence for higher levels of use of
traditional healthcare in some areas of the study site
than others.
The variables examined in this study were selected on
the basis of either reports of significant associations with
the use of traditional medicine in previous studies [27,35]
or a priori assumptions about their significance. A
deceased individual was categorised as either a permanent
resident if they dwelt in the study site for more than
6 months of the year preceding the household follow-up
visit prior to their death or a temporary migrant if they
dwelt in the site for 6 months or less. Individuals were
assigned Mozambican origin if they either in-migrated from
Mozambique or had a father classified Mozambican. Other
than those from Mozambique all other residents reported
South Africa as their country of origin. Individual educa-
tional attainment was calculated from the number of years
of full time education successfully completed. Household
socio-economic position (SEP) is a measure of asset owner-
ship. It was derived from data on features such as the type
of household building materials used, access to water and
fuel and the ownership of appliances, livestock and
transport. From these data 5 sub-indicators were con-
structed within which each asset variable was equally
weighted. The sub-indicators were combined and stan-
dardised leading to the derivation of an absolute SEP
score [53,54]. Using the SEP score, households were
ordered into asset status quintiles with quintile 1 repre-
senting the households with the least assets and quintile 5
those with the most. The duration of the final illness is
based on the recollection of the VA respondents. The
prior mortality rate at an individual’s dwelling was
included in order to obtain a measure of the mortality
experience of those who were co-resident with the de-
ceased. This was calculated by dividing the total number
of deaths in the dwelling by the total number of person
years for all residents, accumulated over the period that
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Analyst module, the road distances between each dwelling
and the closest health centre were calculated.
Data were analysed using Stata version 10.0 [55]. Cross-
tabulations with Chi-squared calculations for categorical
variables and t-tests for continuous variables were used to
assess the significance of associations between variables and
the impact of missing data. Two-sample tests of proportions
were used to calculate 95% confidence intervals (CI) for per-
centages and to compare differences between percentages
for different causes of death in the same time period.
Logistic regression models were developed for those
assigned to have died of HIV/AIDS and TB using an initial
series of bivariate models with an outcome of 1 if the de-
ceased used traditional or herbal treatments at any time
during the final illness. A weighting term scaled from 0.4
to 1.0 was introduced in the regression to account for the
likelihood of the cause of death as assigned by the
InterVA-4 model. Continuous variables which showed an
independent association with the outcome (p < 0.10) and
categorical variables where there was an association in
at least one category (p < 0.10) were included in theFigure 1 Short title - Residential locations and traditional healthcare
map shows the geographical distribution of the home location for those usin
anonymity the geographical coordinates are randomly shifted in the range +multivariate model. In order to understand whether the
associations with TH use changed over time, interaction
terms were introduced between each variable in the multi-
variate model and time period. Significant interactions
were identified if the p-value in one category of the inter-
action term was less than 0.1 and the introduction of the
interaction term improved the predictive power of the
model as evidenced by an increase in the log likelihood.
Ethics
Ethical clearance for the collection of data used in this study
was given by the University of the Witwatersrand Human
Research Ethics Committee (Medical) clearance certificates
M960720 and M110138 ‘Investigating and Responding to
Changes in the Health and Population Dynamics of Rural
South Africans’. Verbal consent was obtained from each re-
spondent prior to every follow-up survey.
Results
There were 6392 deaths recorded for those aged 18 years
and over between 2003 and 2011. Health care utilisation
(HCU) data was available for 5929 individuals (92.8%),use for those dying between 2003 and 2011. Detailed legend - This
g traditional or herbal medicines during their final illness. To preserve
/− 0.5 km in the X and Y directions.
Table 1 Characteristics of the study population1
Characteristic n % (95% CI)
Total 5929 100.0
Gender Female 2831 47.7 (46.0 - 49.5)
Male 3098 52.3 (50.4 - 54.1)
Age at death
(years)
18 to 49 3283 55.4 (53.5 - 57.3)
50 to 65 1167 19.7 (18.6 - 20.8)
>65 1479 24.9 (23.7 - 26.2)
Country of
origin2
Mozambique 1823 30.7 (29.3 - 32.2)
South Africa 4101 69.2 (67.1 - 71.3)
Unknown 5 0.1 (0.0 - 0.2)
Year of death 2003 to 2005 1781 30.0 (28.6 - 31.4)
2006 to 2008 2115 35.7 (34.2 - 37.2)
2009 to 2011 2033 34.3 (32.8 - 35.8)
Residence status Temporary 1629 27.5 (26.1 - 28.8)
Permanent 4166 70.3 (68.1 - 72.4)
Unknown 134 2.3 (1.9 - 2.6)
Individual education
(years completed)
0 to 5 2845 48.0 (46.2 - 49.7)
6 to 7 672 11.3 (10.5 - 12.2)
8 to 9 620 10.5 (9.6 - 11.3)
10 to 11 638 10.8 (9.9 - 11.6)
>11 921 15.5 (14.5 - 16.5)
Unknown 233 3.9 (3.4 - 4.4)
Household SEP
quintile3
1 1142 19.3 (18.1 - 20.4)
2 1249 21.1 (19.9 - 22.2)
3 1141 19.2 (18.1 - 20.4)
4 1205 20.3 (19.2 - 21.5)
5 1128 19.0 (17.9 - 20.1)




0 - 1 1925 32.5 (31.0 - 33.9)
1 - 3 1497 25.2 (24.0 - 26.5)
>3 2507 42.3 (40.6 - 43.9)
Illness duration
(months)
0 to 1 1923 32.4 (31.0 - 33.9)
>1 to 2 621 10.5 (9.7 - 11.3)
>2 to 6 1195 20.2 (19.0 - 21.3)
>6 to 24 1142 19.3 (18.1 - 20.4)
>24 279 4.7 (4.2 - 5.3)




0 2872 48.4 (46.7 - 50.2)
>0 - 10 1243 21.0 (19.8 - 22.1)
>10 - 20 985 16.6 (15.6 - 17.7)
>20 829 14.0 (13.0 - 14.9)
Table 1 Characteristics of the study population1
(Continued)
Cause of death HIV/AIDS and TB 2833 47.8 (46.0 - 49.5)
Other 2409 40.6 (39.0 - 42.3)
External 362 6.1 (5.5 - 6.7)
Unknown 325 5.5 (4.9 - 6.1)
1The study population comprises adults (aged over 18) who died in the
Agincourt sub-district between 2003 and 2011 for whom healthcare utilisation
data was available.
2South Africa indicates those born in South Africa, Mozambique represents
those who either in-migrated from Mozambique or were the children of
fathers in-migrating from Mozambique.
3SEP (socioeconomic position) quintiles are a measure of the level of asset
ownership in a household. Quintile 1 includes the households with the lowest
levels of asset ownership and quintile 5 those with the highest levels.
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Table S1). The geographical distribution of the households
and TH use status of those who died is shown in Figure 1.
There was no indication from this of variations in likeli-
hood of TH use amongst the deceased across the site. The
characteristics of the study population are shown in
Table 1. There were 2833 deaths attributable to HIV/AIDS
and TB, 47.8% of the total.
An assessment was made of the effect of excluding in-
dividuals from the study population due to missing
HCU data (Additional file 2: Table S1). The entire popu-
lation of deceased had a higher percentage of deaths of
unknown cause than the study population (p < 0.001)
and the distribution of illness duration categories dif-
fered between the two groups (p < 0.001) although there
was no evidence for a difference in the mean values of ill-
ness duration. For those dying of HIV/AIDS and TB, re-
ported TH use decreased from 77.5% to 38.5% between
2003–2005 and 2009–2011, whilst for those dying of other
causes the decrease was from 53.6% to 23.6% (Figure 2 &
Additional file 2: Table S2). The level of TH use for those
dying of HIV/AIDS and TB was significantly higher than
that for those dying of other causes in all three time pe-
riods (p < 0.001 in each case). A decrease in the percent-
age of deaths for which TH use was the first treatment
option was seen for HIV/AIDS and TB and other causes
of death between 2006–2008 and 2009–2011. First use of
TH was significantly higher for those dying of HIV/AIDS
and TB than for those dying of other causes in 2006–2008
but not in 2009-2011(Figure 2 & Additional file 2: Table
S3).The level of reported dual use of biomedical treatment
and TH was significantly higher for those dying of HIV/
AIDS and TB than for those dying of other causes in each
time period. In both CoD categories there were large
decreases in the percentage using both biomedical treat-
ments and traditional and herbal medicines between each
successive time period (Figure 2 & Additional file 2: Table
S4). The percentage of deaths for which only biomedical
treatment was reported was higher for those dying of
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Figure 2 Short title – Patterns of healthcare use amongst those dying of HIV/AIDS and TB in the study population between 2003 and 2011 stratified by cause of death. Legend – This
plot shows the percentage of the study population dying in each 3 year period for which a particular category of traditional and/or biomedical healthcare use was reported in the verbal autopsy
interview. The study population comprises adults (aged over 18) who died in the Agincourt sub-district between 2003 and 2011 for whom healthcare utilisation data was available. Vertical lines
indicate the 95% confidence intervals. Diagonal shading indicates that the p-value for the difference in percentages in the type of healthcare usage between the two cause of death categories in

























Table 2 Bivariate and multivariate logistic regression analyses of determinants of any traditional healthcare use
amongst those dying of HIV/AIDS in the study population1
Bivariate analysis Multivariate analysis
Characteristics Category Total N (%) Odds ratio 95% CI (p value) Odds ratio 95% CI (p value)
Gender Female 1430 879 (61.47) 1 (ref)
Male 1403 828 (59.02) 0.90 0.77 - 1.05 (0.198)
Age at death (years) 18 - 49 1974 1194 (60.49) 1 (ref)
50 – 65 533 325 (60.98) 1.01 0.83 - 1.24 (0.903)
>65 326 188 (57.67) 0.88 0.69 - 1.12 (0.304)
Country of origin2 Mozambique 936 602 (64.32) 1 (ref) 1(ref)
South Africa 1894 1104 (58.29) 0.77 0.65 - 0.91 (0.002) 0.72 0.60 - 0.87 (0.001)
Year of death 2003 - 2005 979 759 (77.53) 1 (ref) 1(ref)
2006 - 2008 1067 645 (60.45) 0.44 0.36 - 0.54 (<0.001) 0.50 0.40 - 0.61 (<0.001)
2009 - 2011 787 303 (38.50) 0.18 0.15 - 0.22 (<0.001) 0.23 0.18 - 0.29 (<0.001)
Residence status Temporary 801 476 (59.43) 1 (ref)
Permanent 1949 1187 (60.90) 1.06 0.89 - 1.26 (0.529)
Individual education
(years completed)
0 to 5 1165 744 (63.86) 1 (ref) 1(ref)
6 to 7 361 217 (60.11) 0.84 0.66 - 1.08 (0.178) 1.06 0.81 - 1.38 (0.669)
8 to 9 332 208 (62.65) 0.94 0.72 - 1.21 (0.62) 1.24 0.93 - 1.64 (0.138)
10 to 11 360 206 (57.22) 0.75 0.59 - 0.96 (0.024) 1.10 0.84 - 1.45 (0.482)
>11 486 262 (53.91) 0.67 0.54 - 0.84 (<0.001) 0.93 0.73 - 1.19 (0.572)
Household SEP quintile3 1 602 376 (62.46) 1 (ref)
2 643 398 (61.90) 0.97 0.77 - 1.23 (0.815)
3 533 320 (60.04) 0.91 0.71 - 1.16 (0.452)
4 554 320 (57.76) 0.84 0.66 - 1.07 (0.152)
5 473 279 (58.99) 0.86 0.67 - 1.11 (0.262)
Road distance to nearest health
centre or clinic (km)
0 - 1 907 538 (59.32) 1 (ref) 1(ref)
1 - 3 730 466 (63.84) 1.22 0.99 - 1.50 (0.058) 1.14 0.91 - 1.42 (0.253)
>3 1196 703 (58.78) 0.98 0.81 - 1.17 (0.787) 1.03 0.84 - 1.25 (0.795)
Illness duration (months) 0 to 1 419 164 (39.14) 1 (ref) 1(ref)
>1 to 2 401 193 (48.13) 1.43 1.07 - 1.91 (0.014) 1.31 0.97 - 1.77 (0.081)
>2 to 6 798 480 (60.15) 2.37 1.84 - 3.04 (<0.001) 2.16 1.66 - 2.80 (<0.001)
>6 to 24 847 620 (73.20) 4.24 3.28 - 5.49 (<0.001) 2.84 2.16 - 3.73 (<0.001)
>24 191 151 (79.06) 5.85 3.88 - 8.80 (<0.001) 2.79 1.81 - 4.32 (<0.001)
Prior Mortality rate in residence
(deaths/1000 PYO)
0 1329 777 (58.47) 1 (ref) 1(ref)
>0 - 10 568 347 (61.09) 1.10 0.89 - 1.35 (0.374) 1.06 0.84 - 1.32 (0.634)
>10 - 20 478 305 (63.81) 1.27 1.02 - 1.59 (0.034) 1.13 0.89 - 1.44 (0.304)
>20 458 278 (60.70) 1.09 0.87 - 1.36 (0.472) 1.01 0.79 - 1.28 (0.956)
1The study population comprises adults (aged over 18) who died in the Agincourt sub-district between 2003 and 2011 for whom healthcare utilisation data
was available.
2South Africa indicates those born in South Africa, Mozambique represents those who either inmigrated from Mozambique or were the children of fathers
in-migrating from Mozambique.
3SEP (socioeconomic position) quintiles are a measure of the level of asset ownership in a household. Quintile 1 includes the households with the lowest levels of
asset ownership and quintile 5 those with the highest levels.
Mee et al. BMC Complementary and Alternative Medicine 2014, 14:504 Page 8 of 13
http://www.biomedcentral.com/1472-6882/14/5042003 to 2005 (27.2% vs. 18.2% ) and 2006 to 2008 (44.4%
vs. 36.6%) (Figure 2 and Additional file 2: Table S5). How-
ever in 2009 to 2011 sole use of biomedical treatment was
reported for 49.9% of HIV/AIDS and TB deaths and45.3% of deaths due to other causes, the difference be-
tween the two was significant (p = 0.035).
A bivariate logistic regression analysis was carried out
in order to assess which variables were individually
Table 3 Interaction terms included1 in the multivariate logistic regression model of traditional healthcare use amongst
the study population2
Determinant Comparison Period Odds ratio 95% Confidence interval p value
Country of origin3 (SA/Moz) 2003-2005 1 (ref)
(SA/Moz) 2006-2008 1.48 0.94 - 2.32 (0.089)
(SA/Moz) 2009-2011 1.36 0.84 - 2.18 (0.209)
Education status
(years of education completed)
6 - 7/0 - 5 2003-2005 1 (ref)
6 - 7/0 - 5 2006-2008 1.05 0.54 - 2.02 (0.887)
6 - 7/0 - 5 2009-2011 0.97 0.48 - 1.98 (0.944)
8 - 9/0 - 5 2003-2005 1 (ref)
8 - 9/0 - 5 2006-2008 0.79 0.39 - 1.58 (0.501)
8 - 9/0 - 5 2009-2011 0.92 0.44 - 1.92 (0.825)
10 - 11/0 - 5 2003-2005 1 (ref)
10 - 11/0 - 5 2006-2008 0.73 0.36 - 1.49 (0.389)
10 - 11/0 - 5 2009-2011 0.63 0.31 - 1.29 (0.209)
>11/0 - 5 2003-2005 1 (ref)
>11/0 - 5 2006-2008 1.10 0.62 - 1.95 (0.743)
>11/0 - 5 2009-2011 1.71 0.92 - 3.17 (0.088)
1Interaction terms were included when a p value < 0.1 was seen for at least one level of the interaction.
2The study population comprised adults (aged over 18) who died of HIV/AIDS related conditions or tuberculosis in the Agincourt sub-district between 2003 and
2011 for whom healthcare utilisation data was available.
3SA represents those born in South Africa, Moz represents those who either in-migrated from Mozambique or were the children of fathers in-migrating
from Mozambique.
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of HIV/AIDS and TB (Table 2). Higher TH use was seen
for those with: Mozambican origin (compared to South
Africans), lower levels of education, homes 1–3 km from
the nearest clinic (compared to those living within 1 km),
longer illness duration and a prior mortality rate in their
dwelling of 10–20 deaths/1000 PYO (compared to no
deaths). After controlling for the effect of other variables
in a multivariate analysis it was found that Mozambicans
used TH more than South Africans, there was a signifi-
cant decrease in TH use in each subsequent 3-year period
and the level of TH use increased with increasing duration
of illness. For the other variables included in the model,
the significance seen in the bivariate analysis was lost.
In 2003–2005 the level of TH use was higher for those
of Mozambican origin than for South Africans. By 2006–
2008 TH use remained higher for Mozambicans but there
was evidence from the interaction term (Table 3) that the
difference had decreased. (Odds Ratio between the two
periods 1.48 95% CI 0.94 – 2.32 p 0.089). In 2003–2005
TH use was lower for those who had completed secondary
education than for those with less than 5 years of educa-
tion. Again there was evidence from the interaction term
(Table 3) that by 2009–2011 this difference had decreased
(Odds Ratio 1.71 95% CI 0.92 – 3.17 p 0.088).
A subsequent analysis in which the CoD likelihoods
were not used as weights in the regression made only
small numerical differences to the odds ratios and no
differences to the associations.Discussion
We carried out an analysis comparing the prevalence of
traditional healthcare (TH) use between those dying of
HIV/AIDS-related disease and pulmonary tuberculosis
(HIV/AIDS and TB) and those dying of other causes.
The study was located in a rural area of South Africa
and analysed data on deaths occurring between 2003 and
2011 a period of time when antiretroviral therapy (ART)
became available within the study area. We also sought to
identify determinants predictive of TH use amongst those
dying of HIV/AIDS and TB in this population.
Over the period of the study, reported TH use decreased
by approximately 50% amongst both those dying of HIV/
AIDS and TB and those dying of other causes. The level
of TH use amongst those dying of HIV/AIDS and TB was
significantly higher than that for those dying of other
causes throughout the period of the study. Similar
decreases in concomitant use of TH and biomedical treat-
ment during the final illness were also seen. Decreases in
the number reporting that TH was sought prior to bio-
medical treatment were also seen in each cause of death
(CoD) category. There was some evidence of the decrease
occurring later for those dying of HIV/AIDS and TB than
for those dying of other causes. In 2003–2005, the per-
centage reporting that only biomedical treatment was
used during the deceased’s final illness was lower amongst
those dying of HIV/AIDS and TB than those dying of
other causes. By 2009–2011 this had reversed and the
level of sole use of biomedical treatment was higher for
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use were found to be associated with an earlier year of
death, longer duration of the illness and Mozambican ori-
gin in multivariate logistic regression models in which the
effect of other variables was controlled for.
In this study no associations were identified between
higher levels of TH use amongst those dying of HIV/AIDS
and TB and various socio-demographic characteristics
such as age, gender, education level and socio-economic
position (SEP). In contrast Sato and colleagues surveying
traditional medicine use in Ghana identified an association
between rising income and an increased use of biomedical
treatment whereas decreasing income was associated with
a greater use of traditional medicine [38]. Two previous
South African studies [27,34] found that lower wealth, as
indicated by grant receipt or lower asset ownership were
associated with increased use of TH. The fact that in the
study area ART was available at no cost from 2007
onwards may explain these differences. It has also been
reported that patterns of TH use appear to vary widely
across the country [9] which may be another explanation
for the differences.
There was evidence from the interaction terms added to
the multivariate model that the relative differences
between South Africans and Mozambicans in the levels of
TH use for those dying of HIV/AIDS and TB decreased
between 2003–2005 and 2006–2008. Similarly when con-
sidering the effect of education the models indicated that
the relative differences in levels of TH use between those
who had completed their secondary level of education and
those who had not completed primary education de-
creased between 2006–2008 and 2009–2011. This would
imply that as the overall level of TH use decreased, educa-
tional attainment and country of origin were no longer
important determinants of TH use in this population.
A strength of this study is that data on healthcare use
patterns were collected consistently prior to and during
the period of the ART roll-out. Previous studies
[1,3,9,21,33,35-37] being cross-sectional are not able to re-
flect this changing temporal dynamic. Also as we were
able to assign causality to each death in an objective man-
ner, we were able to assess whether changing use patterns
were disease specific or more general.
A limitation with our study is that the data set com-
prised only individuals who had died. This was a subset of
all of the sick who either did not receive treatment or for
whom the treatment was unsuccessful. It is difficult to as-
sess the direction of bias when these results are compared
to population surveys of healthcare use amongst the
living. As an individual is likely to have much higher levels
of use of biomedical or traditional healthcare in the final
stages of their illness, this may be representative of
changes in the whole population; however, further studies
are needed to confirm this. As the reports of healthcareuse come from care-givers of the deceased, these may be
inaccurate due to recall bias and a possible lack of involve-
ment in the deceased’s healthcare in the early stages of the
illness. It may also be that a perception amongst the
respondents of the lack of approval by biomedical practi-
tioners and researchers made them less likely to report
TH use. However, our use of fieldworkers who are mem-
bers of the same community as the respondents who were
specifically trained to deal with confidential and sensitive
data should lessen the risk of inaccurate data being given.
Also as data was collected from a care-giver rather than
the individual themselves the respondent could not
personally be stigmatised due to information given. The
data was collected prior to a cause of death being assigned
so neither the fieldworkers or the caregiver would know
the death was assigned as due to HIV/AIDS at the time of
the interview, we are not aware of stigmatisation associated
with consulting traditional practitioners for medical condi-
tions other than HIV/AIDS. As we do not have data on the
specific types of treatment provided by either the traditional
or biomedical practitioners we cannot draw any firm con-
clusions about the level of concomitant ART and herbal
medicine use. Also due to specific cultural and social fac-
tors different patterns and determinants of use may occur
in other areas of rural South Africa and sub-Saharan Africa.
Following from the ideas on how healthcare choices are
made in this community, as put forward by Golooba-
Mutebi and Tollman in 2002 [28], it may be hypothesised
that the decrease in TH use was a response to personal,
family or community experience of the effectiveness of
ART. This may be coupled with a lessening in associated
stigma and greater acceptance of HIV-related illness in
these communities.
Conclusions
In conclusion, prior to the availability of ART, traditional
herbal or spiritual therapies were the only healthcare
options available in this community for those with HIV-
related disease. With the decentralised ART roll-out and
improved access to treatment there was a decrease in
HIV-associated mortality and a decrease in TH use. The
persisting high levels of concomitant use of traditional
and biomedical treatment for HIV-related disease are a
potential cause for concern amongst biomedical practi-
tioners due to the possibility of antagonistic interactions
between ART drugs and the traditional herbal treatments.
A recent Mozambican study indicated a willingness on
the part of traditional practitioners to engage with allo-
pathic providers, but noted that the success of previous
initiatives to achieve this had been limited [56]. A review
of projects across sub-Saharan Africa to integrate trad-
itional medical practitioners with biomedical providers
has shown that the sectors can work effectively together
but highlighted the need for more effective evaluation of
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practice for such projects [5].
Based on our findings, both regular repeated cross-
sectional analyses of healthcare use and in-depth qualitative
studies of the rapidly changing patterns of healthcare would
be useful to enable us to gain a better understanding of
changes in health seeking behavior in this community in re-
sponse to the developing HIV pandemic and the availability
of ART.
Additional files
Additional file 1: Agincourt verbal autopsy health care utilization
instrument. This form was used to collect the data on the use made of
different types of healthcare by the deceased person during the final
stages of the illness.
Additional file 2: Table S1. Comparison of descriptive variables for the
entire population (those dying between 2003 and 2011 in the Agincourt
HDSS) and the study population (the subset of the entire population for
whom healthcare utilisation data was available). Tables S2–S5 comparisons
of the percentages of those dying between 2003 and 2011 for different
categories of biomedical and traditional healthcare use. The categories used
are as follows. Table S2. Any use of traditional or herbal treatment during
final illness. Table S3. First use of traditional or herbal treatment in the
healthcare seeking pathway during the final illness. Table S4. Use of
both traditional or herbal treatments and biomedical treatments during
the final illness. Table S5. Sole use of biomedical treatment during the
final illness.
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